WO2022234737A1 - Produit cosmétique émulsifié de type huile dans l'eau - Google Patents
Produit cosmétique émulsifié de type huile dans l'eau Download PDFInfo
- Publication number
- WO2022234737A1 WO2022234737A1 PCT/JP2022/013232 JP2022013232W WO2022234737A1 WO 2022234737 A1 WO2022234737 A1 WO 2022234737A1 JP 2022013232 W JP2022013232 W JP 2022013232W WO 2022234737 A1 WO2022234737 A1 WO 2022234737A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- oil
- less
- cosmetic
- shaped structure
- disc
- Prior art date
Links
- 239000002537 cosmetic Substances 0.000 title claims abstract description 110
- 239000000463 material Substances 0.000 title claims abstract description 13
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 59
- 239000008346 aqueous phase Substances 0.000 claims abstract description 14
- 239000002612 dispersion medium Substances 0.000 claims abstract description 10
- 239000003921 oil Substances 0.000 claims description 115
- 235000014113 dietary fatty acids Nutrition 0.000 claims description 38
- 239000000194 fatty acid Substances 0.000 claims description 38
- 229930195729 fatty acid Natural products 0.000 claims description 38
- -1 fatty acid ester Chemical class 0.000 claims description 27
- 229920002545 silicone oil Polymers 0.000 claims description 19
- 150000004665 fatty acids Chemical class 0.000 claims description 16
- 229920000223 polyglycerol Polymers 0.000 claims description 11
- 125000004432 carbon atom Chemical group C* 0.000 claims description 5
- 238000010030 laminating Methods 0.000 claims description 3
- 239000003995 emulsifying agent Substances 0.000 abstract description 18
- 238000004945 emulsification Methods 0.000 abstract description 14
- 235000019198 oils Nutrition 0.000 description 108
- 239000002245 particle Substances 0.000 description 18
- 239000000839 emulsion Substances 0.000 description 17
- 238000011156 evaluation Methods 0.000 description 14
- 239000000203 mixture Substances 0.000 description 13
- 239000004094 surface-active agent Substances 0.000 description 13
- 239000004166 Lanolin Substances 0.000 description 10
- 239000004205 dimethyl polysiloxane Substances 0.000 description 10
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 10
- 230000000694 effects Effects 0.000 description 10
- 235000019388 lanolin Nutrition 0.000 description 10
- 229940039717 lanolin Drugs 0.000 description 10
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 10
- 239000001993 wax Substances 0.000 description 10
- 239000012071 phase Substances 0.000 description 9
- 239000006096 absorbing agent Substances 0.000 description 7
- 239000010410 layer Substances 0.000 description 7
- 238000002360 preparation method Methods 0.000 description 6
- 238000012360 testing method Methods 0.000 description 6
- 230000015572 biosynthetic process Effects 0.000 description 5
- 239000003795 chemical substances by application Substances 0.000 description 5
- 230000000052 comparative effect Effects 0.000 description 5
- 239000003814 drug Substances 0.000 description 5
- 238000009472 formulation Methods 0.000 description 5
- 239000007788 liquid Substances 0.000 description 5
- 238000000034 method Methods 0.000 description 5
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 5
- 239000004215 Carbon black (E152) Substances 0.000 description 4
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 4
- 235000015278 beef Nutrition 0.000 description 4
- POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid Chemical compound CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 description 4
- 229940079593 drug Drugs 0.000 description 4
- 229930195733 hydrocarbon Natural products 0.000 description 4
- 150000002430 hydrocarbons Chemical class 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 230000035515 penetration Effects 0.000 description 4
- 239000007921 spray Substances 0.000 description 4
- 239000000341 volatile oil Substances 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- SGVYKUFIHHTIFL-UHFFFAOYSA-N Isobutylhexyl Natural products CCCCCCCC(C)C SGVYKUFIHHTIFL-UHFFFAOYSA-N 0.000 description 3
- TUNFSRHWOTWDNC-UHFFFAOYSA-N Myristic acid Natural products CCCCCCCCCCCCCC(O)=O TUNFSRHWOTWDNC-UHFFFAOYSA-N 0.000 description 3
- 239000003012 bilayer membrane Substances 0.000 description 3
- 230000005540 biological transmission Effects 0.000 description 3
- 239000002270 dispersing agent Substances 0.000 description 3
- POULHZVOKOAJMA-UHFFFAOYSA-M dodecanoate Chemical compound CCCCCCCCCCCC([O-])=O POULHZVOKOAJMA-UHFFFAOYSA-M 0.000 description 3
- 230000001804 emulsifying effect Effects 0.000 description 3
- 210000002472 endoplasmic reticulum Anatomy 0.000 description 3
- 239000003925 fat Substances 0.000 description 3
- 235000019197 fats Nutrition 0.000 description 3
- 230000002209 hydrophobic effect Effects 0.000 description 3
- 229940070765 laurate Drugs 0.000 description 3
- 239000006210 lotion Substances 0.000 description 3
- 239000007764 o/w emulsion Substances 0.000 description 3
- 230000003287 optical effect Effects 0.000 description 3
- 239000003760 tallow Substances 0.000 description 3
- DSEKYWAQQVUQTP-XEWMWGOFSA-N (2r,4r,4as,6as,6as,6br,8ar,12ar,14as,14bs)-2-hydroxy-4,4a,6a,6b,8a,11,11,14a-octamethyl-2,4,5,6,6a,7,8,9,10,12,12a,13,14,14b-tetradecahydro-1h-picen-3-one Chemical compound C([C@H]1[C@]2(C)CC[C@@]34C)C(C)(C)CC[C@]1(C)CC[C@]2(C)[C@H]4CC[C@@]1(C)[C@H]3C[C@@H](O)C(=O)[C@@H]1C DSEKYWAQQVUQTP-XEWMWGOFSA-N 0.000 description 2
- RKJGFHYCZPZJPE-UHFFFAOYSA-N 2,2-bis(16-methylheptadecanoyloxymethyl)butyl 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OCC(CC)(COC(=O)CCCCCCCCCCCCCCC(C)C)COC(=O)CCCCCCCCCCCCCCC(C)C RKJGFHYCZPZJPE-UHFFFAOYSA-N 0.000 description 2
- BANXPJUEBPWEOT-UHFFFAOYSA-N 2-methyl-Pentadecane Chemical compound CCCCCCCCCCCCCC(C)C BANXPJUEBPWEOT-UHFFFAOYSA-N 0.000 description 2
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 2
- CMBYOWLFQAFZCP-UHFFFAOYSA-N Hexyl dodecanoate Chemical compound CCCCCCCCCCCC(=O)OCCCCCC CMBYOWLFQAFZCP-UHFFFAOYSA-N 0.000 description 2
- 239000005639 Lauric acid Substances 0.000 description 2
- IMNFDUFMRHMDMM-UHFFFAOYSA-N N-Heptane Chemical compound CCCCCCC IMNFDUFMRHMDMM-UHFFFAOYSA-N 0.000 description 2
- DRRMRHKHTQRWMB-UHFFFAOYSA-N [3-(2-ethylhexanoyloxy)-2,2-bis(2-ethylhexanoyloxymethyl)propyl] 2-ethylhexanoate Chemical compound CCCCC(CC)C(=O)OCC(COC(=O)C(CC)CCCC)(COC(=O)C(CC)CCCC)COC(=O)C(CC)CCCC DRRMRHKHTQRWMB-UHFFFAOYSA-N 0.000 description 2
- 125000002015 acyclic group Chemical group 0.000 description 2
- 150000001298 alcohols Chemical class 0.000 description 2
- 239000012298 atmosphere Substances 0.000 description 2
- 125000004429 atom Chemical group 0.000 description 2
- 238000009835 boiling Methods 0.000 description 2
- 239000010495 camellia oil Substances 0.000 description 2
- 239000004359 castor oil Substances 0.000 description 2
- 235000019438 castor oil Nutrition 0.000 description 2
- 235000019864 coconut oil Nutrition 0.000 description 2
- 239000003240 coconut oil Substances 0.000 description 2
- 125000004122 cyclic group Chemical group 0.000 description 2
- 229940008099 dimethicone Drugs 0.000 description 2
- 239000002552 dosage form Substances 0.000 description 2
- 125000000524 functional group Chemical group 0.000 description 2
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 2
- 125000003976 glyceryl group Chemical group [H]C([*])([H])C(O[H])([H])C(O[H])([H])[H] 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 2
- 229940100463 hexyl laurate Drugs 0.000 description 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 229940119170 jojoba wax Drugs 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- 229940105132 myristate Drugs 0.000 description 2
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 2
- OQILCOQZDHPEAZ-UHFFFAOYSA-N octyl palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OCCCCCCCC OQILCOQZDHPEAZ-UHFFFAOYSA-N 0.000 description 2
- 150000002894 organic compounds Chemical class 0.000 description 2
- 239000000049 pigment Substances 0.000 description 2
- XOJVVFBFDXDTEG-UHFFFAOYSA-N pristane Chemical compound CC(C)CCCC(C)CCCC(C)CCCC(C)C XOJVVFBFDXDTEG-UHFFFAOYSA-N 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 229940032094 squalane Drugs 0.000 description 2
- 239000002562 thickening agent Substances 0.000 description 2
- 229940118594 trimethylolpropane triisostearate Drugs 0.000 description 2
- BJDAUCLANVMIOB-UHFFFAOYSA-N (3-decanoyloxy-2,2-dimethylpropyl) decanoate Chemical compound CCCCCCCCCC(=O)OCC(C)(C)COC(=O)CCCCCCCCC BJDAUCLANVMIOB-UHFFFAOYSA-N 0.000 description 1
- RUHCWQAFCGVQJX-RVWHZBQESA-N (3s,8s,9s,10r,13r,14s,17r)-3-hydroxy-10,13-dimethyl-17-[(2r)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-1-one Chemical compound C1C=C2C[C@H](O)CC(=O)[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 RUHCWQAFCGVQJX-RVWHZBQESA-N 0.000 description 1
- YYGNTYWPHWGJRM-UHFFFAOYSA-N (6E,10E,14E,18E)-2,6,10,15,19,23-hexamethyltetracosa-2,6,10,14,18,22-hexaene Chemical compound CC(C)=CCCC(C)=CCCC(C)=CCCC=C(C)CCC=C(C)CCC=C(C)C YYGNTYWPHWGJRM-UHFFFAOYSA-N 0.000 description 1
- QMMJWQMCMRUYTG-UHFFFAOYSA-N 1,2,4,5-tetrachloro-3-(trifluoromethyl)benzene Chemical compound FC(F)(F)C1=C(Cl)C(Cl)=CC(Cl)=C1Cl QMMJWQMCMRUYTG-UHFFFAOYSA-N 0.000 description 1
- WAYINTBTZWQNSN-UHFFFAOYSA-N 11-methyldodecyl 3,5,5-trimethylhexanoate Chemical compound CC(C)CCCCCCCCCCOC(=O)CC(C)CC(C)(C)C WAYINTBTZWQNSN-UHFFFAOYSA-N 0.000 description 1
- 229940043268 2,2,4,4,6,8,8-heptamethylnonane Drugs 0.000 description 1
- HFWHTGSLDKKCMD-UHFFFAOYSA-N 2,2-bis(octanoyloxymethyl)butyl octanoate Chemical compound CCCCCCCC(=O)OCC(CC)(COC(=O)CCCCCCC)COC(=O)CCCCCCC HFWHTGSLDKKCMD-UHFFFAOYSA-N 0.000 description 1
- JNAYPSWVMNJOPQ-UHFFFAOYSA-N 2,3-bis(16-methylheptadecanoyloxy)propyl 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCCCC(C)C)COC(=O)CCCCCCCCCCCCCCC(C)C JNAYPSWVMNJOPQ-UHFFFAOYSA-N 0.000 description 1
- DGSZGZSCHSQXFV-UHFFFAOYSA-N 2,3-bis(2-ethylhexanoyloxy)propyl 2-ethylhexanoate Chemical compound CCCCC(CC)C(=O)OCC(OC(=O)C(CC)CCCC)COC(=O)C(CC)CCCC DGSZGZSCHSQXFV-UHFFFAOYSA-N 0.000 description 1
- TWJNQYPJQDRXPH-UHFFFAOYSA-N 2-cyanobenzohydrazide Chemical compound NNC(=O)C1=CC=CC=C1C#N TWJNQYPJQDRXPH-UHFFFAOYSA-N 0.000 description 1
- OUCGJMIVSYHBEC-UHFFFAOYSA-N 2-ethylhexyl 2-ethylhexanoate Chemical compound CCCCC(CC)COC(=O)C(CC)CCCC OUCGJMIVSYHBEC-UHFFFAOYSA-N 0.000 description 1
- SFAAOBGYWOUHLU-UHFFFAOYSA-N 2-ethylhexyl hexadecanoate Chemical compound CCCCCCCCCCCCCCCC(=O)OCC(CC)CCCC SFAAOBGYWOUHLU-UHFFFAOYSA-N 0.000 description 1
- WSSJONWNBBTCMG-UHFFFAOYSA-N 2-hydroxybenzoic acid (3,3,5-trimethylcyclohexyl) ester Chemical compound C1C(C)(C)CC(C)CC1OC(=O)C1=CC=CC=C1O WSSJONWNBBTCMG-UHFFFAOYSA-N 0.000 description 1
- GTJOHISYCKPIMT-UHFFFAOYSA-N 2-methylundecane Chemical compound CCCCCCCCCC(C)C GTJOHISYCKPIMT-UHFFFAOYSA-N 0.000 description 1
- ZSNLEVJATWJBLU-UHFFFAOYSA-N 2-tert-butyl-2-methoxy-1,3-diphenylpropane-1,3-dione Chemical compound C=1C=CC=CC=1C(=O)C(C(C)(C)C)(OC)C(=O)C1=CC=CC=C1 ZSNLEVJATWJBLU-UHFFFAOYSA-N 0.000 description 1
- UIVPNOBLHXUKDX-UHFFFAOYSA-N 3,5,5-trimethylhexyl 3,5,5-trimethylhexanoate Chemical compound CC(C)(C)CC(C)CCOC(=O)CC(C)CC(C)(C)C UIVPNOBLHXUKDX-UHFFFAOYSA-N 0.000 description 1
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 description 1
- MVJSIAIXMFGVSA-UHFFFAOYSA-N 6-(2-hexyldecoxy)-6-oxohexanoic acid Chemical compound CCCCCCCCC(CCCCCC)COC(=O)CCCCC(O)=O MVJSIAIXMFGVSA-UHFFFAOYSA-N 0.000 description 1
- 241000195940 Bryophyta Species 0.000 description 1
- 244000146553 Ceiba pentandra Species 0.000 description 1
- 235000003301 Ceiba pentandra Nutrition 0.000 description 1
- 241000283153 Cetacea Species 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- XMSXQFUHVRWGNA-UHFFFAOYSA-N Decamethylcyclopentasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 XMSXQFUHVRWGNA-UHFFFAOYSA-N 0.000 description 1
- RDOFJDLLWVCMRU-UHFFFAOYSA-N Diisobutyl adipate Chemical compound CC(C)COC(=O)CCCCC(=O)OCC(C)C RDOFJDLLWVCMRU-UHFFFAOYSA-N 0.000 description 1
- IUMSDRXLFWAGNT-UHFFFAOYSA-N Dodecamethylcyclohexasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 IUMSDRXLFWAGNT-UHFFFAOYSA-N 0.000 description 1
- 102000002322 Egg Proteins Human genes 0.000 description 1
- 108010000912 Egg Proteins Proteins 0.000 description 1
- FPVVYTCTZKCSOJ-UHFFFAOYSA-N Ethylene glycol distearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCOC(=O)CCCCCCCCCCCCCCCCC FPVVYTCTZKCSOJ-UHFFFAOYSA-N 0.000 description 1
- FMRHJJZUHUTGKE-UHFFFAOYSA-N Ethylhexyl salicylate Chemical compound CCCCC(CC)COC(=O)C1=CC=CC=C1O FMRHJJZUHUTGKE-UHFFFAOYSA-N 0.000 description 1
- 235000018330 Macadamia integrifolia Nutrition 0.000 description 1
- 240000000912 Macadamia tetraphylla Species 0.000 description 1
- 235000003800 Macadamia tetraphylla Nutrition 0.000 description 1
- RGMZNZABJYWAEC-UHFFFAOYSA-N Methyltris(trimethylsiloxy)silane Chemical compound C[Si](C)(C)O[Si](C)(O[Si](C)(C)C)O[Si](C)(C)C RGMZNZABJYWAEC-UHFFFAOYSA-N 0.000 description 1
- 239000004909 Moisturizer Substances 0.000 description 1
- 235000021360 Myristic acid Nutrition 0.000 description 1
- 241000772415 Neovison vison Species 0.000 description 1
- YBGZDTIWKVFICR-JLHYYAGUSA-N Octyl 4-methoxycinnamic acid Chemical compound CCCCC(CC)COC(=O)\C=C\C1=CC=C(OC)C=C1 YBGZDTIWKVFICR-JLHYYAGUSA-N 0.000 description 1
- 235000019482 Palm oil Nutrition 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- 235000019483 Peanut oil Nutrition 0.000 description 1
- 235000004347 Perilla Nutrition 0.000 description 1
- 244000124853 Perilla frutescens Species 0.000 description 1
- 239000004264 Petrolatum Substances 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 235000001630 Pyrus pyrifolia var culta Nutrition 0.000 description 1
- 244000079529 Pyrus serotina Species 0.000 description 1
- 235000019484 Rapeseed oil Nutrition 0.000 description 1
- 235000019774 Rice Bran oil Nutrition 0.000 description 1
- 240000000111 Saccharum officinarum Species 0.000 description 1
- 235000007201 Saccharum officinarum Nutrition 0.000 description 1
- 235000019485 Safflower oil Nutrition 0.000 description 1
- 241000270666 Testudines Species 0.000 description 1
- BHEOSNUKNHRBNM-UHFFFAOYSA-N Tetramethylsqualene Natural products CC(=C)C(C)CCC(=C)C(C)CCC(C)=CCCC=C(C)CCC(C)C(=C)CCC(C)C(C)=C BHEOSNUKNHRBNM-UHFFFAOYSA-N 0.000 description 1
- 244000299461 Theobroma cacao Species 0.000 description 1
- 235000005764 Theobroma cacao ssp. cacao Nutrition 0.000 description 1
- 235000005767 Theobroma cacao ssp. sphaerocarpum Nutrition 0.000 description 1
- 235000006732 Torreya nucifera Nutrition 0.000 description 1
- 244000111306 Torreya nucifera Species 0.000 description 1
- 208000000260 Warts Diseases 0.000 description 1
- CMPDPBDUZTUXAD-UHFFFAOYSA-N [3-hydroxy-2-(16-methylheptadecanoyloxy)propyl] 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OCC(CO)OC(=O)CCCCCCCCCCCCCCC(C)C CMPDPBDUZTUXAD-UHFFFAOYSA-N 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000002730 additional effect Effects 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 239000000443 aerosol Substances 0.000 description 1
- 150000001336 alkenes Chemical class 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 235000021302 avocado oil Nutrition 0.000 description 1
- 239000008163 avocado oil Substances 0.000 description 1
- 239000012179 bayberry wax Substances 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 235000013871 bee wax Nutrition 0.000 description 1
- 239000012166 beeswax Substances 0.000 description 1
- XVAMCHGMPYWHNL-UHFFFAOYSA-N bemotrizinol Chemical compound OC1=CC(OCC(CC)CCCC)=CC=C1C1=NC(C=2C=CC(OC)=CC=2)=NC(C=2C(=CC(OCC(CC)CCCC)=CC=2)O)=N1 XVAMCHGMPYWHNL-UHFFFAOYSA-N 0.000 description 1
- HGKOWIQVWAQWDS-UHFFFAOYSA-N bis(16-methylheptadecyl) 2-hydroxybutanedioate Chemical compound CC(C)CCCCCCCCCCCCCCCOC(=O)CC(O)C(=O)OCCCCCCCCCCCCCCCC(C)C HGKOWIQVWAQWDS-UHFFFAOYSA-N 0.000 description 1
- WMNULTDOANGXRT-UHFFFAOYSA-N bis(2-ethylhexyl) butanedioate Chemical compound CCCCC(CC)COC(=O)CCC(=O)OCC(CC)CCCC WMNULTDOANGXRT-UHFFFAOYSA-N 0.000 description 1
- FQUNFJULCYSSOP-UHFFFAOYSA-N bisoctrizole Chemical compound N1=C2C=CC=CC2=NN1C1=CC(C(C)(C)CC(C)(C)C)=CC(CC=2C(=C(C=C(C=2)C(C)(C)CC(C)(C)C)N2N=C3C=CC=CC3=N2)O)=C1O FQUNFJULCYSSOP-UHFFFAOYSA-N 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 235000014121 butter Nutrition 0.000 description 1
- 235000001046 cacaotero Nutrition 0.000 description 1
- 239000004204 candelilla wax Substances 0.000 description 1
- 235000013868 candelilla wax Nutrition 0.000 description 1
- 229940073532 candelilla wax Drugs 0.000 description 1
- 239000004203 carnauba wax Substances 0.000 description 1
- 235000013869 carnauba wax Nutrition 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000002738 chelating agent Substances 0.000 description 1
- 229940114081 cinnamate Drugs 0.000 description 1
- 238000013329 compounding Methods 0.000 description 1
- 235000005687 corn oil Nutrition 0.000 description 1
- 239000002285 corn oil Substances 0.000 description 1
- 235000012343 cottonseed oil Nutrition 0.000 description 1
- 239000002385 cottonseed oil Substances 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- SASYSVUEVMOWPL-NXVVXOECSA-N decyl oleate Chemical compound CCCCCCCCCCOC(=O)CCCCCCC\C=C/CCCCCCCC SASYSVUEVMOWPL-NXVVXOECSA-N 0.000 description 1
- 239000008367 deionised water Substances 0.000 description 1
- 229910021641 deionized water Inorganic materials 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 229940105984 diethylhexyl succinate Drugs 0.000 description 1
- 229940031769 diisobutyl adipate Drugs 0.000 description 1
- 229940031569 diisopropyl sebacate Drugs 0.000 description 1
- 239000000539 dimer Substances 0.000 description 1
- KWABLUYIOFEZOY-UHFFFAOYSA-N dioctyl butanedioate Chemical compound CCCCCCCCOC(=O)CCC(=O)OCCCCCCCC KWABLUYIOFEZOY-UHFFFAOYSA-N 0.000 description 1
- 229940090934 diphenylsiloxy phenyl trimethicone Drugs 0.000 description 1
- XFKBBSZEQRFVSL-UHFFFAOYSA-N dipropan-2-yl decanedioate Chemical compound CC(C)OC(=O)CCCCCCCCC(=O)OC(C)C XFKBBSZEQRFVSL-UHFFFAOYSA-N 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 235000013345 egg yolk Nutrition 0.000 description 1
- 210000002969 egg yolk Anatomy 0.000 description 1
- 239000000686 essence Substances 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 229940068171 ethyl hexyl salicylate Drugs 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 230000001815 facial effect Effects 0.000 description 1
- 238000005562 fading Methods 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 229940100608 glycol distearate Drugs 0.000 description 1
- 239000003676 hair preparation Substances 0.000 description 1
- IUJAMGNYPWYUPM-UHFFFAOYSA-N hentriacontane Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC IUJAMGNYPWYUPM-UHFFFAOYSA-N 0.000 description 1
- IPCSVZSSVZVIGE-UHFFFAOYSA-M hexadecanoate Chemical compound CCCCCCCCCCCCCCCC([O-])=O IPCSVZSSVZVIGE-UHFFFAOYSA-M 0.000 description 1
- XJNUECKWDBNFJV-UHFFFAOYSA-N hexadecyl 2-ethylhexanoate Chemical compound CCCCCCCCCCCCCCCCOC(=O)C(CC)CCCC XJNUECKWDBNFJV-UHFFFAOYSA-N 0.000 description 1
- OGEMCJNRDGZFQF-UHFFFAOYSA-N hexyl 2-benzoyl-4-(diethylamino)-3-hydroxybenzoate Chemical compound CCCCCCOC(=O)C1=CC=C(N(CC)CC)C(O)=C1C(=O)C1=CC=CC=C1 OGEMCJNRDGZFQF-UHFFFAOYSA-N 0.000 description 1
- 229960004881 homosalate Drugs 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- VKPSKYDESGTTFR-UHFFFAOYSA-N isododecane Natural products CC(C)(C)CC(C)CC(C)(C)C VKPSKYDESGTTFR-UHFFFAOYSA-N 0.000 description 1
- 229940100554 isononyl isononanoate Drugs 0.000 description 1
- KUVMKLCGXIYSNH-UHFFFAOYSA-N isopentadecane Natural products CCCCCCCCCCCCC(C)C KUVMKLCGXIYSNH-UHFFFAOYSA-N 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- XUGNVMKQXJXZCD-UHFFFAOYSA-N isopropyl palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC(C)C XUGNVMKQXJXZCD-UHFFFAOYSA-N 0.000 description 1
- 238000003475 lamination Methods 0.000 description 1
- 235000021388 linseed oil Nutrition 0.000 description 1
- 239000000944 linseed oil Substances 0.000 description 1
- 239000002502 liposome Substances 0.000 description 1
- 229940057995 liquid paraffin Drugs 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 229940073663 methyl trimethicone Drugs 0.000 description 1
- 239000004200 microcrystalline wax Substances 0.000 description 1
- 235000019808 microcrystalline wax Nutrition 0.000 description 1
- 229940114937 microcrystalline wax Drugs 0.000 description 1
- 238000013508 migration Methods 0.000 description 1
- 230000005012 migration Effects 0.000 description 1
- 239000003595 mist Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000001333 moisturizer Effects 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- 239000012170 montan wax Substances 0.000 description 1
- 235000011929 mousse Nutrition 0.000 description 1
- 229940078812 myristyl myristate Drugs 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
- 239000002120 nanofilm Substances 0.000 description 1
- 239000000346 nonvolatile oil Substances 0.000 description 1
- 239000010466 nut oil Substances 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- HMMGMWAXVFQUOA-UHFFFAOYSA-N octamethylcyclotetrasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 HMMGMWAXVFQUOA-UHFFFAOYSA-N 0.000 description 1
- WWZKQHOCKIZLMA-UHFFFAOYSA-N octanoic acid Chemical compound CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 description 1
- 229960001679 octinoxate Drugs 0.000 description 1
- FMJSMJQBSVNSBF-UHFFFAOYSA-N octocrylene Chemical group C=1C=CC=CC=1C(=C(C#N)C(=O)OCC(CC)CCCC)C1=CC=CC=C1 FMJSMJQBSVNSBF-UHFFFAOYSA-N 0.000 description 1
- 229960000601 octocrylene Drugs 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- JRZJOMJEPLMPRA-UHFFFAOYSA-N olefin Natural products CCCCCCCC=C JRZJOMJEPLMPRA-UHFFFAOYSA-N 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 239000003346 palm kernel oil Substances 0.000 description 1
- 235000019865 palm kernel oil Nutrition 0.000 description 1
- 239000002540 palm oil Substances 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 239000000312 peanut oil Substances 0.000 description 1
- 229940066842 petrolatum Drugs 0.000 description 1
- 235000019271 petrolatum Nutrition 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 229920000575 polymersome Polymers 0.000 description 1
- 229940100498 polysilicone-15 Drugs 0.000 description 1
- 229920002282 polysilicones-15 Polymers 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 239000003380 propellant Substances 0.000 description 1
- 239000008165 rice bran oil Substances 0.000 description 1
- 235000005713 safflower oil Nutrition 0.000 description 1
- 239000003813 safflower oil Substances 0.000 description 1
- 235000003441 saturated fatty acids Nutrition 0.000 description 1
- 150000004671 saturated fatty acids Chemical class 0.000 description 1
- 239000003352 sequestering agent Substances 0.000 description 1
- 235000011803 sesame oil Nutrition 0.000 description 1
- 239000008159 sesame oil Substances 0.000 description 1
- 239000002453 shampoo Substances 0.000 description 1
- 239000012176 shellac wax Substances 0.000 description 1
- 239000002356 single layer Substances 0.000 description 1
- 201000010153 skin papilloma Diseases 0.000 description 1
- 238000000235 small-angle X-ray scattering Methods 0.000 description 1
- 235000002316 solid fats Nutrition 0.000 description 1
- 235000012424 soybean oil Nutrition 0.000 description 1
- 239000003549 soybean oil Substances 0.000 description 1
- 229940031439 squalene Drugs 0.000 description 1
- TUHBEKDERLKLEC-UHFFFAOYSA-N squalene Natural products CC(=CCCC(=CCCC(=CCCC=C(/C)CCC=C(/C)CC=C(C)C)C)C)C TUHBEKDERLKLEC-UHFFFAOYSA-N 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 150000005846 sugar alcohols Polymers 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 239000013501 sustainable material Substances 0.000 description 1
- 239000008399 tap water Substances 0.000 description 1
- 235000020679 tap water Nutrition 0.000 description 1
- TUNFSRHWOTWDNC-HKGQFRNVSA-N tetradecanoic acid Chemical compound CCCCCCCCCCCCC[14C](O)=O TUNFSRHWOTWDNC-HKGQFRNVSA-N 0.000 description 1
- DZKXJUASMGQEMA-UHFFFAOYSA-N tetradecyl tetradecanoate Chemical compound CCCCCCCCCCCCCCOC(=O)CCCCCCCCCCCCC DZKXJUASMGQEMA-UHFFFAOYSA-N 0.000 description 1
- BOJSDHZZKKYWAS-UHFFFAOYSA-N tetrakis(trimethylsilyl)silane Chemical compound C[Si](C)(C)[Si]([Si](C)(C)C)([Si](C)(C)C)[Si](C)(C)C BOJSDHZZKKYWAS-UHFFFAOYSA-N 0.000 description 1
- 235000015961 tonic Nutrition 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 229960000716 tonics Drugs 0.000 description 1
- 229940098385 triisostearin Drugs 0.000 description 1
- 239000013638 trimer Substances 0.000 description 1
- BUBJWNWWARPCBH-UHFFFAOYSA-N tris(trimethylsilyl)methylsilicon Chemical compound C[Si](C)(C)C([Si])([Si](C)(C)C)[Si](C)(C)C BUBJWNWWARPCBH-UHFFFAOYSA-N 0.000 description 1
- 229910021642 ultra pure water Inorganic materials 0.000 description 1
- 239000012498 ultrapure water Substances 0.000 description 1
- 239000006097 ultraviolet radiation absorber Substances 0.000 description 1
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 1
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 229920003169 water-soluble polymer Polymers 0.000 description 1
- 239000010497 wheat germ oil Substances 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/04—Dispersions; Emulsions
- A61K8/06—Emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/31—Hydrocarbons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/37—Esters of carboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
- A61K8/86—Polyethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
- A61K8/89—Polysiloxanes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
Definitions
- the present disclosure relates to oil-in-water emulsified cosmetics.
- oil-in-water emulsion compositions that can be used in cosmetics are prepared using emulsifiers.
- various emulsifiers have been developed in order to obtain oil-in-water emulsion compositions with excellent emulsion stability.
- Patent Document 1 discloses an oil-in-water emulsified composition prepared using an emulsifying dispersant whose main component is a closed endoplasmic reticulum (vesicle) formed by an amphiphilic substance with self-organizing ability.
- oil-in-water emulsified cosmetics in addition to emulsifiers (surfactants), various materials such as oils, thickeners, and moisturizers are used.
- emulsifiers surfactants
- various materials such as oils, thickeners, and moisturizers are used.
- oil-in-water emulsified cosmetics it has been desired to increase the variety of emulsifiers so that such materials can be used as appropriate.
- the subject of the present disclosure is to provide an oil-in-water emulsified cosmetic prepared using a novel emulsifier and having excellent emulsion stability.
- An oil-in-water emulsified cosmetic comprising The oil droplets contain oil and a disc-shaped structure, The disk-shaped structure is formed by laminating monomolecular films having a hydrophilic portion and a lipophilic portion, and is arranged at the interface between the oil droplet and the aqueous phase.
- the oil is at least one selected from the group consisting of polar oils and silicone oils.
- an oil-in-water emulsified cosmetic prepared using a novel emulsifier and having excellent emulsion stability.
- FIG. 2 is a schematic diagram showing the state of arrangement of disk-shaped structures at the interface between oil droplets and the aqueous phase of the oil-in-water emulsified cosmetic according to one embodiment of the present disclosure.
- the oil-in-water emulsified cosmetic of the present disclosure includes a dispersion medium containing water and oil droplets dispersed in the dispersion medium, the oil droplets including oil and disk-shaped structures, and the disk-shaped structures are , a monomolecular film having a hydrophilic portion and a lipophilic portion are laminated to each other and arranged at the interface between the oil droplet and the water phase.
- the disc-shaped structure functions as an emulsifier, and the principle of action for obtaining an oil-in-water emulsified cosmetic with excellent emulsion stability is as follows. I think that it is as follows.
- the disc-shaped structure of the present disclosure is composed of two vesicles formed by vesicles formed in the aqueous phase, for example, collapsing under the influence of oil in the cosmetic.
- the bilayer membrane that constitutes the vesicle via the hydrophilic part of the monomolecular film or the monomolecular membranes forming the bilayer membrane of the vesicle are laminated with the hydrophilic portions interposed therebetween or with the lipophilic portions interposed therebetween.
- the disc-shaped structure is formed of a monomolecular film having a hydrophilic portion and a lipophilic portion that constitute the bilayer of the vesicle.
- the lipophilic portion hydrophobic portion
- the hydrophilic portion is arranged at the interface with the water phase, so that the laminate as a whole is similar to an emulsifier. I think it can work.
- a monomolecular film having a hydrophilic portion and a lipophilic portion itself has the ability to emulsify oil. Therefore, when this monomolecular film material is used as an emulsifier to emulsify water and oil, the monomolecular film material does not stack in a layered manner, and the oil droplets and the aqueous phase are not laminated in the same way as common emulsifiers. is thought to be oriented near the interface of Under such conditions, the material of the monolayer generally does not remain near the interface with the aqueous phase in the oil droplets (emulsified particles), e.g., in the aqueous phase or at the interface of other adjacent oil droplets. is considered to be in an equilibrium state in which the As a result, the oil is exposed at the interface of the oil droplets, and tends to aggregate and coalesce with the oil in other adjacent oil droplets, which is likely to reduce the emulsion stability.
- a monomolecular film having a hydrophilic portion and a lipophilic portion is arranged in the form of a disk-shaped structure laminated in layers at the interface between the oil droplets and the aqueous phase.
- this disc-shaped structure is thought to have reduced or suppressed migration in the aqueous phase or at the interface of other adjacent oil droplets, compared to common emulsifiers.
- the oil is less likely to be exposed at the interface of the oil droplets and less likely to aggregate and coalesce with the oil in other adjacent oil droplets, thus improving the emulsification stability.
- the oil-in-water emulsified cosmetic containing the disc-shaped structure of the present disclosure can also improve the occlusion effect (the effect of preventing moisture from escaping from the skin) as an incidental effect. This is because when the cosmetic of the present disclosure is applied to the skin, the disc-shaped structures in the cosmetic are arranged so as to cover the skin surface, so evaporation of moisture from the skin can be reduced or prevented. I think it's for the sake of
- oil-in-water emulsified cosmetic containing the disk-shaped structure of the present disclosure can improve permeation feeling, moist feeling, usability (stickiness resistance), film resistance feeling, etc. as additional effects. .
- the emulsifying dispersant described in Patent Document 1 uses the vesicle itself, which is a closed endoplasmic reticulum, as an emulsifier, and is different from the disc-shaped structure in the present disclosure.
- the term “disc-shaped structure” does not form a closed endoplasmic reticulum structure like a vesicle, and the cross-sectional shape of such a structure is substantially plate-shaped as shown in FIG. (eg, generally square, generally rectangular) are contemplated.
- the term “substantially” means that the cross-sectional shape of such a structure is not allowed to be spherical like a vesicle, but is deformed to some extent, for example, deformed so as to exhibit a curvature along the shape of an oil droplet. is intended to be acceptable.
- Liposomes in the present disclosure also include liposomes and polymersomes.
- the dispersion medium (aqueous phase) in the oil-in-water emulsified cosmetic of the present disclosure (sometimes simply referred to as “cosmetics”) contains water.
- the amount of water to be blended is not particularly limited, and for example, from the viewpoint of emulsion stability, 20% by mass or more, 30% by mass or more, 40% by mass or more, 50% by mass or more, and 60% by mass of the total amount of the cosmetic. 70% by mass or more, or 80% by mass or more, and 90% by mass or less, 80% by mass or less, 70% by mass or less, 60% by mass or less, or 50% by mass or less .
- the water that can be used in the oil-in-water emulsified cosmetic of the present disclosure is not particularly limited, and for example, water used in cosmetics and quasi-drugs can be used.
- water used in cosmetics and quasi-drugs can be used.
- deionized water, distilled water, ultrapure water, and tap water can be used.
- the oil droplets as the oil phase or dispersed phase in the oil-in-water emulsified cosmetic of the present disclosure contain an oil component and a disc-shaped structure.
- the average particle size of the oil droplets can be, for example, 10 ⁇ m or less, 7 ⁇ m or less, 5 ⁇ m or less, or 3 ⁇ m or less immediately after production.
- the lower limit of the average particle diameter is not particularly limited, it can be, for example, 500 nm or more, 700 nm or more, or 1 ⁇ m or more.
- the average particle diameter of the oil droplets can be defined as the average value of the projected area circle equivalent diameters of 10 or more, preferably 100 or more oil droplets observed with an optical microscope.
- oil content in the oil-in-water emulsion cosmetic of the present disclosure is 1.0% by mass or more, 2.0% by mass or more, 3.0% by mass or more, and 5.0% by mass with respect to the total amount of the cosmetic. 7.0% by mass or more, 10% by mass or more, 15% by mass or more, 20% by mass or more, 25% by mass or more, or 30% by mass or more, and 50% by mass or less, 45% by mass or more 40% by mass or less, 35% by mass or less, 30% by mass or less, 25% by mass or less, 20% by mass or less, 15% by mass or less, or 10% by mass or less.
- the oil content is preferably 45% by mass or less, more preferably 40% by mass or less, relative to the total amount of the cosmetic, from the viewpoint of emulsion stability and the like.
- oils for example, volatile and non-volatile oils can be used.
- An oil component can be used individually or in combination of 2 or more types.
- volatile is intended to exhibit a volatile content of more than 5% when left at 105°C under atmospheric pressure for 3 hours.
- the volatile content which is a guideline for volatility, can be 10% or more, 20% or more, 40% or more, 50% or more, 60% or more, 80% or more, or 100%.
- the boiling point at 1 atmosphere (101.325 kPa) can be used as an indicator of volatility.
- the boiling point can be 250° C. or lower, 240° C.
- non-volatile intends to exhibit a volatile content of 5% or less when left at 105°C for 3 hours.
- the volatile oil is not particularly limited, and examples include volatile silicone oil and volatile hydrocarbon oil. Among these, volatile silicone oils are preferable from the viewpoint of reducing the average particle size of oil droplets.
- a volatile oil can be used individually or in combination of 2 or more types.
- Volatile silicone oils include, for example, volatile acyclic silicone oils and volatile cyclic silicone oils.
- volatile acyclic silicone oils for example, volatile linear silicone oils and volatile branched silicone oils can be used.
- Volatile linear silicone oils include, for example, dimethylpolysiloxane with a viscosity of 0.65 cs (sometimes referred to as “dimethicone"), dimethylpolysiloxane with a viscosity of 1 cs, dimethylpolysiloxane with a viscosity of 1.5 cs, and dimethylpolysiloxane with a viscosity of 2 cs. and low-molecular-weight linear dimethylpolysiloxane such as dimethylpolysiloxane.
- dimethylpolysiloxane having a viscosity of 2 cs is more preferable from the viewpoint of reducing the average particle size of oil droplets.
- these viscosities are intended to be kinematic viscosities at 25°C.
- Volatile branched silicone oils include, for example, low-molecular-weight branched siloxanes such as methyltrimethicone, tris(trimethylsilyl)methylsilane, and tetrakis(trimethylsilyl)silane.
- Volatile cyclic silicone oils include, for example, octamethylcyclotetrasiloxane, decamethylcyclopentasiloxane, and dodecamethylcyclohexasiloxane.
- Volatile hydrocarbon oils include, for example, heptane, isododecane, isohexadecane, and isodecane.
- oils include oils commonly used in cosmetics, such as liquid oils, solid oils, waxes, hydrocarbon oils other than those mentioned above, silicone oils other than those mentioned above, and polar oils. can be done. Among these, silicone oil is preferable from the viewpoint of reducing the average particle size of oil droplets.
- some UV absorbers act as oils, especially polar oils. Such ultraviolet absorbers can also be regarded as oils.
- liquid oils examples include avocado oil, camellia oil, turtle oil, macadamia nut oil, corn oil, mink oil, olive oil, rapeseed oil, egg yolk oil, sesame oil, persic oil, wheat germ oil, sasanqua oil, castor oil, and linseed oil. , safflower oil, cottonseed oil, perilla oil, soybean oil, peanut oil, tea seed oil, kaya oil, rice bran oil, sinagi oil, Japanese pear oil, jojoba oil, germ oil, and triglycerin.
- solid fats and oils examples include cacao butter, coconut oil, horse fat, hydrogenated coconut oil, palm oil, beef tallow, mutton tallow, hydrogenated beef tallow, palm kernel oil, lard, beef bone fat, Japanese wax kernel oil, hydrogenated oil, beef Leg fat, Japanese wax, and hydrogenated castor oil.
- Waxes include, for example, beeswax, candelilla wax, cotton wax, carnauba wax, bayberry wax, wart wax, whale wax, montan wax, bran wax, lanolin, kapok wax, lanolin acetate, liquid lanolin, sugarcane wax, isopropyl lanolin fatty acid, hexyl laurate, Reduced lanolin, jojoba wax, hard lanolin, shellac wax, POE lanolin alcohol ether, POE lanolin alcohol acetate, POE cholesterol ether, lanolin fatty acid polyethylene glycol, and POE hydrogenated lanolin alcohol ether.
- hydrocarbon oils examples include liquid paraffin, ozokerite, squalane, pristane, paraffin, ceresin, squalene, petrolatum, microcrystalline wax, and olefin oligomers.
- squalane is preferable from the viewpoint of emulsion stability.
- silicone oils examples include linear silicones such as dimethylpolysiloxane (dimethicone), methylphenylpolysiloxane (diphenylsiloxyphenyltrimethicone), and methylhydrogenpolysiloxane having a viscosity of 6 cs or more.
- polar oil for example, a polar oil with an IOB of 0.10 or more can be used.
- a ultraviolet absorber can be used individually or in combination of 2 or more types.
- the IOB value of the polar oil and UV absorber can be, for example, 0.11 or more, 0.12 or more, or 0.13 or more, and 0.50 or less, 0.45 or less, or 0.40 or less.
- the IOB value is an abbreviation for Inorganic/Organic Balance (inorganic/organic ratio), which is a value representing the ratio of the inorganic value to the organic value, and is an index indicating the degree of polarity of an organic compound. It becomes.
- polar oils are at least one selected from the group consisting of polar oils and silicone oils.
- the polar oil is at least one polyglycerin fatty acid ester having an OH/C ratio of 0.30 to 0.60, preferably 0.35 to 0.60, more preferably 0.40 to 0.60, which will be described later.
- the average oil droplet size can be reduced.
- silicone oil is also advantageous as it can reduce the average particle size of the oil droplets.
- the disc-shaped structure of the present disclosure which is a novel emulsifier, is formed by laminating monomolecular films having a hydrophilic portion and a lipophilic portion, and is arranged at the interface between the oil droplet and the aqueous phase. .
- the number of laminated monomolecular films can be 3 or more, or 5 or more.
- the upper limit of the number of layers to be laminated is not particularly limited, and may be, for example, 15 layers or less, 13 layers or less, 11 layers or less, 9 layers or less, or 7 layers or less.
- the maximum length of one side of the cross-sectional shape of the disk-shaped structure for example, the length in the width direction of the disk-shaped structure in FIG. or less, or 30 nm or more, 40 nm or more, or 50 nm or more.
- the maximum length is intended to be the length of the curved surface as shown in FIG. .
- the presence or absence of a disk-shaped structure and the maximum length of one side of the cross-sectional shape of the disk-shaped structure are determined using a frozen replica transmission electron microscope (TEM, H-7650: manufactured by Hitachi, Ltd.). It can be confirmed or obtained from the photograph.
- the maximum length of one side of the cross-sectional shape of the disk-shaped structure is the average value of 10 arbitrarily selected disk-shaped structures.
- the disc-shaped structure is formed by the vesicles in the aqueous phase collapsing, and the monomolecular membrane of the bilayer membrane that constitutes the vesicle is partially replaced by the lipophilic part (hydrophobic part). After being adsorbed on the surface of the oil via the , are considered to be formed by lamination with hydrophilic portions interposed therebetween or oleophilic portions interposed therebetween. That is, the monomolecular film of the disk-like structure is typically composed of at least one kind of surfactant capable of forming vesicles.
- the presence or absence of vesicles in cosmetics can be determined, for example, by a frozen replica method using a frozen replica transmission electron microscope (TEM, H-7650: manufactured by Hitachi, Ltd.), or by a small-angle X-ray scattering measurement device (SAXSess, Anton Paar) and Zetasizer Nano (Malvern Panalytical).
- TEM frozen replica transmission electron microscope
- SAXSess small-angle X-ray scattering measurement device
- SAtasizer Nano Malvern Panalytical
- the amount of the surfactant that constitutes the disk-shaped structure is 0.1% by mass or more and 0.1% by mass or more, based on the total amount of the cosmetic, from the viewpoint of the formability of the disk-shaped structure, emulsion stability, occlusion effect, etc. .3 mass % or more, or 0.5 mass % or more, and 10 mass % or less, 5.0 mass % or less, or 3.0 mass % or less.
- the disc-shaped structure of the present disclosure can highly emulsify oil.
- the emulsifying ability of the oil can be evaluated by the ratio of the mass of the oil to the mass of the surfactant forming the disk-shaped structure.
- Such a mass ratio can be, for example, 20 or more, 30 or more, 40 or more, or 50 or more, and can be 90 or less, 85 or less, or 80 or less.
- polyglycerin fatty acid esters can be preferably used from the viewpoint of formability of the disc-shaped structure, emulsion stability, and the like.
- This polyglycerin fatty acid ester is a sustainable material, and as an incidental effect, it can provide a moist feeling when applied to the skin, and can improve the occlusion effect.
- Polyglycerol fatty acid esters can be used alone or in combination of two or more.
- Polyglycerin fatty acid esters can be prepared by esterifying fatty acids with polyglycerin as shown in the following reaction scheme:
- the portion derived from fatty acids can be called a fatty acid portion
- the portion derived from polyglycerin can be called a polyglycerin portion.
- the fatty acid portion corresponds to the lipophilic portion
- the polyglycerol portion corresponds to the hydrophilic portion.
- the polyglycerol fatty acid ester preferably has a fatty acid moiety with 12 or more, 13 or more, or 14 or more carbon atoms from the viewpoint of disk-shaped structure formability, emulsion stability, occlusion effect, and the like. , 17 or less, 16 or less, or 15 or less.
- Fatty acids that can be used when preparing polyglycerol fatty acid esters may be saturated fatty acids or unsaturated fatty acids, and may be linear fatty acids or branched fatty acids.
- Such fatty acids can include, for example, lauric acid, myristic acid, and palmitic acid. Among them, myristic acid and lauric acid are preferred.
- the polyglycerin portion of the polyglycerin fatty acid ester is preferably a trimer or higher or a tetramer or higher from the viewpoint of disk-shaped structure formability, emulsion stability, occlusion effect, etc.
- it is preferably an octamer or less, a heptamer or less, or a hexamer or less, and more preferably a tetramer or more and an octamer or less.
- the numerical value of n of the polyglycerol fatty acid ester in the above reaction formula matches, for example, the numerical value of 2 in the dimer.
- the disc-shaped structure is preferably made of at least one polyglycerin fatty acid ester having an OH/C ratio of 0.30 to 0.80.
- the OH/C ratio is preferably 0.30 or more, 0.35 or more, 0.40 or more, 0.45 or more, or 0.50 or more, and is 0.80 or less, 0.75 or less, It is preferably 0.70 or less, 0.65 or less, or 0.60 or less.
- a polyglycerol fatty acid ester having such an OH/C ratio easily forms a disc-shaped structure, and can further improve the emulsion stability, occlusion effect, etc. of the oil-in-water emulsified cosmetic.
- the "OH/C ratio" in the present disclosure means the ratio of the number of hydroxyl groups in the polyglycerin portion to the number of carbon atoms in the fatty acid portion, and is a parameter relating to the balance between hydrophilicity and lipophilicity.
- polyglycerol fatty acid esters include polyglyceryl-6 myristate, polyglyceryl-4 laurate, polyglyceryl-5 laurate, polyglyceryl-6 laurate, and polyglyceryl-10 palmitate.
- the oil-in-water emulsified cosmetic composition of the present disclosure can be appropriately blended with various components within a range that does not affect the effects of the present disclosure.
- various components include additive components that can be usually blended in cosmetics, such as surfactants other than surfactants that constitute the disk-shaped structure, moisturizing agents, thickeners, water-soluble polymers, and highly oil-soluble ingredients.
- Molecules film-forming agents, higher fatty acids, sequestering agents, lower alcohols, higher alcohols, polyhydric alcohols, various extracts, sugars, amino acids, organic amines, polymer emulsions, chelating agents, other than the above UV absorbers UV absorbers, pH adjusters, skin nutrients, vitamins, pharmaceuticals, quasi-drugs, water-soluble agents applicable to cosmetics, buffers, anti-fading agents, preservatives, dispersants, propellants, fillers , pigments, dyes, pigments, fragrances, and the like.
- Optional components can be blended in the oil phase and/or the water phase, and can be used alone or in combination of two or more.
- the disc-shaped structure in the oil-in-water emulsified cosmetic of the present disclosure functions as an emulsifier. Therefore, a surfactant other than the surfactant that constitutes the disc-shaped structure may be blended in the cosmetic, but from the viewpoint of the formability of the disc-shaped structure, the emulsion stability, etc., such a surfactant
- the amount of the agent is 5.0% by mass or less, 3.0% by mass or less, 1.0% by mass or less, 0.5% by mass or less, or 0.1% by mass or less with respect to the total amount of the cosmetic. is preferred, and it is more preferred not to incorporate such a surfactant.
- the oil-in-water emulsified cosmetic composition of the present disclosure has a viscosity of 25 Pa s or less and 23 Pa s or less immediately after preparation of the cosmetic composition as measured using the conditions and apparatus described in the examples below. ⁇ s or less, 20 Pa ⁇ s or less, or 19 Pa ⁇ s or less, or 1.0 Pa ⁇ s or more, 1.5 Pa ⁇ s or more, or 2.0 Pa ⁇ s or more.
- Such a viscosity of the cosmetic immediately after preparation can be referred to as "initial viscosity”.
- the oil-in-water emulsified cosmetic of the present disclosure has a pH of 7.0 or less, 6.8 or less, or 6.0 or less, as measured using the conditions and apparatus described in the examples below. 5 or less.
- the lower limit of the pH of the cosmetic is not particularly limited, it is preferably 5.5 or higher or 6.0 or higher, for example, from the viewpoint of irritation to the skin.
- the oil-in-water emulsified cosmetic of the present disclosure is not limited to the following method, but can be prepared as follows. Various materials described above can be used in the preparation of cosmetics.
- a vesicle solution is formed by mixing a vesicle-forming surfactant such as a polyglycerol fatty acid ester with water optionally containing a water-soluble drug, an aqueous component, and the like. Then, an oil component containing an oil-soluble drug, an oily component, etc. is optionally added to the vesicle solution, and the mixture is stirred and mixed to obtain the oil-in-water emulsified cosmetic composition of the present disclosure.
- a vesicle-forming surfactant such as a polyglycerol fatty acid ester
- water optionally containing a water-soluble drug, an aqueous component, and the like.
- an oil component containing an oil-soluble drug, an oily component, etc. is optionally added to the vesicle solution, and the mixture is stirred and mixed to obtain the oil-in-water emulsified cosmetic composition of the present disclosure.
- the dosage form of the oil-in-water emulsified cosmetic of the present disclosure is not particularly limited, and examples thereof include liquid, milky lotion, cream, gel, spray, and mousse.
- “spray” can include mist type spray, aerosol type spray, and the like.
- oil-in-water emulsified cosmetics can be used, for example, as a cosmetic that is spread and applied to the skin, hair, or the like.
- the product form of the cosmetics of the present disclosure is not particularly limited, but for example, facial cosmetics such as lotions, beauty essences, milky lotions, and packs; makeup cosmetics such as foundations, lipsticks, and eye shadows; body cosmetics; hair cosmetics such as hair liquids, hair tonics, hair conditioners, shampoos, rinses and hair restorers; and ointments.
- the oil-in-water emulsified cosmetic of the present disclosure will be described in more detail below with reference to examples, but the cosmetic of the present disclosure is not limited to these.
- the compounding amount is indicated by mass %.
- ⁇ Evaluation of emulsion stability The size of the oil droplets within 1 hour after preparation of the cosmetic preparation and the size of the oil droplets after storage at 50°C for 4 weeks were observed with an optical microscope, and the emulsification stability was evaluated according to the following criteria.
- a and B ratings can be considered pass and C rating fail: A: Almost no change in oil droplet size.
- C The oil droplet size was obviously increased, or the cosmetic was separated.
- the particle size of the emulsified particles (oil droplets) in the cosmetic is measured by direct visual observation with an optical microscope (BX60, manufactured by OLYMPUS), arbitrarily selecting 10 emulsified particles, and measuring the projected area circle of the emulsified particles. The average equivalent diameter is shown in the table.
- Test Example 1 Emulsification stability of cosmetic along with formation of disc-shaped structure>>
- Test Example 1 the emulsification stability of cosmetics accompanying the formation of disc-shaped structures was examined.
- Table 1 shows the results.
- the emulsification stability of the cosmetics of Comparative Examples 1 and 2 was poor, and thus the particle size, viscosity, and pH of the emulsified particles were not evaluated.
- Example 1 No. 1 to No. 5, No. 12 and no.
- the 13 materials were uniformly mixed to obtain an aqueous phase part containing vesicles.
- Example 2-8 and Comparative Examples 1-2 Oil-in-water emulsified cosmetics of Examples 2-8 and Comparative Examples 1-2 were obtained in the same manner as in Example 1, except that the formulations shown in Table 1 were changed.
- the surfactant is a polyglycerin fatty acid ester
- a disc-shaped structure is easily obtained when the OH/C ratio is about 0.30 to 0.80.
- Test Example 2 Emulsification performance of disc-shaped structure for various oils>>
- Test Example 2 the emulsification performance of the disc-shaped structure for various oil components was examined. The results are shown in Tables 2-3. Tables 2 and 3 also show the results of Examples 3 and 4, respectively.
- Example 9 to 21 Using the formulations shown in Tables 2 and 3, in the same manner as in Example 1, oil-in-water emulsified cosmetics of Examples 9 to 21 were obtained.
- Test Example 3 Various performances such as penetration of cosmetics accompanying the formation of the disc-shaped structure>>
- Test Example 3 in addition to the emulsification stability of the cosmetic along with the formation of the disc-shaped structure, penetration feeling, moist feeling, usability (stickiness) and film feeling were examined.
- Table 4 shows the results.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Emergency Medicine (AREA)
- Dermatology (AREA)
- Chemical & Material Sciences (AREA)
- Dispersion Chemistry (AREA)
- Cosmetics (AREA)
Abstract
L'invention concerne un produit cosmétique émulsifié de type huile dans l'eau qui est préparé à l'aide d'un nouvel émulsifiant et qui présente une excellente stabilité d'émulsification. Un produit cosmétique émulsifié de type huile dans l'eau selon la présente divulgation contient : un milieu de dispersion contenant de l'eau ; et des gouttelettes d'huile dispersées dans le milieu de dispersion. Les gouttelettes d'huile comprennent chacune une teneur en huile et une structure de type disque. Les structures de type disque sont formées par stratification de films monomoléculaires ayant chacun une partie hydrophile et une partie lipophile, et sont disposées au niveau des interfaces des gouttelettes d'huile par rapport à la phase aqueuse.
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2023518635A JPWO2022234737A1 (fr) | 2021-05-06 | 2022-03-22 | |
CN202280027624.5A CN117120019A (zh) | 2021-05-06 | 2022-03-22 | 水包油型乳化化妆料 |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2021078545 | 2021-05-06 | ||
JP2021-078545 | 2021-05-06 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2022234737A1 true WO2022234737A1 (fr) | 2022-11-10 |
Family
ID=83932147
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP2022/013232 WO2022234737A1 (fr) | 2021-05-06 | 2022-03-22 | Produit cosmétique émulsifié de type huile dans l'eau |
Country Status (3)
Country | Link |
---|---|
JP (1) | JPWO2022234737A1 (fr) |
CN (1) | CN117120019A (fr) |
WO (1) | WO2022234737A1 (fr) |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2011241175A (ja) * | 2010-05-18 | 2011-12-01 | Kao Corp | 油/ベシクル/水型乳化組成物及びそれを含有する化粧料 |
JP2017109975A (ja) * | 2015-12-18 | 2017-06-22 | ポーラ化成工業株式会社 | 水中油型乳化組成物 |
JP2020158539A (ja) * | 2020-06-30 | 2020-10-01 | ポーラ化成工業株式会社 | 水中油型乳化組成物 |
-
2022
- 2022-03-22 JP JP2023518635A patent/JPWO2022234737A1/ja active Pending
- 2022-03-22 WO PCT/JP2022/013232 patent/WO2022234737A1/fr active Application Filing
- 2022-03-22 CN CN202280027624.5A patent/CN117120019A/zh active Pending
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2011241175A (ja) * | 2010-05-18 | 2011-12-01 | Kao Corp | 油/ベシクル/水型乳化組成物及びそれを含有する化粧料 |
JP2017109975A (ja) * | 2015-12-18 | 2017-06-22 | ポーラ化成工業株式会社 | 水中油型乳化組成物 |
JP2020158539A (ja) * | 2020-06-30 | 2020-10-01 | ポーラ化成工業株式会社 | 水中油型乳化組成物 |
Also Published As
Publication number | Publication date |
---|---|
CN117120019A (zh) | 2023-11-24 |
JPWO2022234737A1 (fr) | 2022-11-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP5989646B2 (ja) | サッカリドシロキサンコポリマー並びにその調製及び使用方法 | |
JP2012250916A (ja) | 水中油型乳化化粧料 | |
JP5720998B2 (ja) | 化粧料用基剤及びこれを配合してなる化粧料 | |
JP2004269502A (ja) | 水中油型乳化化粧料 | |
JP2012067024A (ja) | 皮膚外用剤 | |
JP5046409B2 (ja) | 水中油型乳化日焼け止め化粧料 | |
EP1192935A2 (fr) | Préparations émulsionnéees de type eau-dans-huile à teneur en eau renforcée | |
WO2012133686A1 (fr) | Agent cosmétique en émulsion d'eau dans l'huile | |
JP5833810B2 (ja) | 水中油型乳化化粧料 | |
KR101824418B1 (ko) | 실리콘 유중수 유화제 및 저 질소 함유 아미노-작용성 실리콘 고무를 포함하는 조성물 | |
JP2009108003A (ja) | 毛髪化粧料 | |
WO2022234737A1 (fr) | Produit cosmétique émulsifié de type huile dans l'eau | |
JP2006273747A (ja) | O/w/o型乳化化粧料 | |
JP4812241B2 (ja) | 毛髪用乳化組成物 | |
JP5547123B2 (ja) | 油中水型乳化化粧料 | |
JP2006241038A (ja) | 乳化化粧料 | |
JP2005314258A (ja) | 固形状油中水型化粧料 | |
JP2004352689A (ja) | 水中油型乳化化粧料 | |
TW201336519A (zh) | 高內水相油中水型乳化組成物 | |
WO2004103324A1 (fr) | Emulsions pour cheveux | |
WO2022234736A1 (fr) | Produit cosmétique comprenant des vésicules | |
JP7496206B2 (ja) | 水中油型乳化組成物 | |
TW201919578A (zh) | 油中水型乳化化妝料 | |
JP7462455B2 (ja) | 水中油型乳化組成物 | |
WO2021177400A1 (fr) | Composition d'émulsion huile dans eau |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 22798844 Country of ref document: EP Kind code of ref document: A1 |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2023518635 Country of ref document: JP |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 22798844 Country of ref document: EP Kind code of ref document: A1 |